Why is ERAS Up Today?
About Erasca, Inc. Common Stock
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm m...
Overall Confidence: 68%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
ACCUMULATION - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: +0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for ERAS's 10% move
No Options Available
ERAS doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get ERAS Alerts
We'll notify you when ERAS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
ERAS has moved more than 3.0% up on 70 occasions in the past year.
Frequently Asked Questions
Why is ERAS stock up today?
Options traders are heavily buying calls on ERAS, with 96% of volume in calls. This suggests bullish institutional positioning.
Is ERAS stock a buy or sell right now?
Based on current analysis, ERAS shows 68% confidence in today's move. Volume is high which supports the trend. View full buy/sell analysis →
What is the ERAS stock price target?
ERAS is currently trading at $17.09. Based on today's momentum, the expected short-term range is $16.74 - $17.60. See long-term price prediction →
Will ERAS stock continue rising?
Our analysis shows a 55% probability that ERAS's move continues in the next 1-3 days. Key level to watch: $17.94 (resistance).
Is ERAS stock oversold or overbought?
ERAS's RSI (Relative Strength Index) is currently at 62.7. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for ERAS stock?
ERAS's 10-day momentum indicator is at 1.97. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is ERAS outperforming or underperforming the market?
ERAS (+10.37%) is currently significantly outperforming the market (+9.1% vs SPY). Today, the S&P 500 (SPY) is up 1.32%, and Nasdaq (QQQ) is up 2.31%.
What does MACD indicate for ERAS?
ERAS's MACD (0.14) is currently above the signal line (-0.12), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 11.7) is weak.
Is ERAS in an uptrend or downtrend?
Based on moving average analysis, ERAS is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $14.68, 50-day SMA: $14.99.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis